

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 4.76784345 |
| 2 | protein complex biogenesis (GO:0070271) | 4.67834451 |
| 3 | DNA deamination (GO:0045006) | 4.39193969 |
| 4 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.26478515 |
| 5 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.21605790 |
| 6 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.21605790 |
| 7 | NADH dehydrogenase complex assembly (GO:0010257) | 4.21605790 |
| 8 | cytochrome complex assembly (GO:0017004) | 4.06776085 |
| 9 | negative regulation of mast cell activation (GO:0033004) | 4.00352198 |
| 10 | negative regulation of telomere maintenance (GO:0032205) | 3.97822717 |
| 11 | GDP-mannose metabolic process (GO:0019673) | 3.97687809 |
| 12 | metallo-sulfur cluster assembly (GO:0031163) | 3.85077210 |
| 13 | iron-sulfur cluster assembly (GO:0016226) | 3.85077210 |
| 14 | peptidyl-histidine modification (GO:0018202) | 3.82762374 |
| 15 | respiratory chain complex IV assembly (GO:0008535) | 3.81524596 |
| 16 | base-excision repair, AP site formation (GO:0006285) | 3.81402040 |
| 17 | mannosylation (GO:0097502) | 3.66773093 |
| 18 | ATP synthesis coupled proton transport (GO:0015986) | 3.55231115 |
| 19 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.55231115 |
| 20 | autophagic vacuole fusion (GO:0000046) | 3.54416510 |
| 21 | pseudouridine synthesis (GO:0001522) | 3.44784186 |
| 22 | tRNA modification (GO:0006400) | 3.44431146 |
| 23 | platelet dense granule organization (GO:0060155) | 3.36176371 |
| 24 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.25777834 |
| 25 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.18209736 |
| 26 | negative regulation of phagocytosis (GO:0050765) | 3.17495602 |
| 27 | regulation of activation of Janus kinase activity (GO:0010533) | 3.16080042 |
| 28 | positive regulation of T cell apoptotic process (GO:0070234) | 3.10561450 |
| 29 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.04941919 |
| 30 | tRNA processing (GO:0008033) | 3.00423858 |
| 31 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.99511268 |
| 32 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.99511268 |
| 33 | regulation of mitochondrial translation (GO:0070129) | 2.97582359 |
| 34 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.94305472 |
| 35 | chaperone-mediated protein transport (GO:0072321) | 2.93623149 |
| 36 | protein insertion into membrane (GO:0051205) | 2.92195588 |
| 37 | electron transport chain (GO:0022900) | 2.91618011 |
| 38 | positive regulation of mitochondrial fission (GO:0090141) | 2.90494691 |
| 39 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.89413094 |
| 40 | regulation of mitochondrial fission (GO:0090140) | 2.89101830 |
| 41 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.86793829 |
| 42 | respiratory electron transport chain (GO:0022904) | 2.86617397 |
| 43 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.86007868 |
| 44 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.80769219 |
| 45 | termination of RNA polymerase III transcription (GO:0006386) | 2.80769219 |
| 46 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.79941107 |
| 47 | L-fucose catabolic process (GO:0042355) | 2.79917259 |
| 48 | fucose catabolic process (GO:0019317) | 2.79917259 |
| 49 | L-fucose metabolic process (GO:0042354) | 2.79917259 |
| 50 | pyrimidine nucleoside salvage (GO:0043097) | 2.77955188 |
| 51 | pyrimidine-containing compound salvage (GO:0008655) | 2.77955188 |
| 52 | kynurenine metabolic process (GO:0070189) | 2.77111532 |
| 53 | cellular response to ATP (GO:0071318) | 2.77058955 |
| 54 | mitochondrial calcium ion transport (GO:0006851) | 2.75585479 |
| 55 | indole-containing compound catabolic process (GO:0042436) | 2.74182836 |
| 56 | indolalkylamine catabolic process (GO:0046218) | 2.74182836 |
| 57 | tryptophan catabolic process (GO:0006569) | 2.74182836 |
| 58 | positive regulation of prostaglandin secretion (GO:0032308) | 2.74171316 |
| 59 | GTP biosynthetic process (GO:0006183) | 2.71587748 |
| 60 | basic amino acid transport (GO:0015802) | 2.71170053 |
| 61 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.71124249 |
| 62 | negative regulation of telomerase activity (GO:0051974) | 2.68643626 |
| 63 | positive regulation of defense response to virus by host (GO:0002230) | 2.67741158 |
| 64 | glutathione biosynthetic process (GO:0006750) | 2.67314651 |
| 65 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.66583077 |
| 66 | organelle membrane fusion (GO:0090174) | 2.66524564 |
| 67 | response to misfolded protein (GO:0051788) | 2.66135433 |
| 68 | negative regulation of cell killing (GO:0031342) | 2.64309162 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.64309162 |
| 70 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.59299360 |
| 71 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.59163748 |
| 72 | deoxyribonucleotide catabolic process (GO:0009264) | 2.55575276 |
| 73 | CTP biosynthetic process (GO:0006241) | 2.54145653 |
| 74 | CTP metabolic process (GO:0046036) | 2.54145653 |
| 75 | regulation of defense response to virus by host (GO:0050691) | 2.52675314 |
| 76 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.51276452 |
| 77 | C-terminal protein lipidation (GO:0006501) | 2.50026337 |
| 78 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.49931464 |
| 79 | response to xenobiotic stimulus (GO:0009410) | 2.49508992 |
| 80 | nucleoside salvage (GO:0043174) | 2.48294680 |
| 81 | NAD biosynthetic process (GO:0009435) | 2.47130533 |
| 82 | amine catabolic process (GO:0009310) | 2.46803217 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 2.46803217 |
| 84 | ubiquinone biosynthetic process (GO:0006744) | 2.45940093 |
| 85 | pentose metabolic process (GO:0019321) | 2.45902218 |
| 86 | indolalkylamine metabolic process (GO:0006586) | 2.45655866 |
| 87 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.41989796 |
| 88 | hydrogen ion transmembrane transport (GO:1902600) | 2.41961107 |
| 89 | tryptophan metabolic process (GO:0006568) | 2.41865372 |
| 90 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.41649361 |
| 91 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.41037535 |
| 92 | synaptic transmission, cholinergic (GO:0007271) | 2.40340501 |
| 93 | positive regulation of protein homooligomerization (GO:0032464) | 2.39485910 |
| 94 | establishment of protein localization to mitochondrion (GO:0072655) | 2.39168286 |
| 95 | regulation of telomerase activity (GO:0051972) | 2.37691923 |
| 96 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.36609272 |
| 97 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.35977405 |
| 98 | opioid receptor signaling pathway (GO:0038003) | 2.35115272 |
| 99 | DNA damage response, detection of DNA damage (GO:0042769) | 2.35104997 |
| 100 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.34797008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.29142805 |
| 2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.01179904 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.79798695 |
| 4 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.60730698 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.45973246 |
| 6 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.34700957 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.30276882 |
| 8 | P68_20966046_ChIP-Seq_HELA_Human | 2.28129503 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.17160847 |
| 10 | BCOR_27268052_Chip-Seq_Bcells_Human | 2.13030325 |
| 11 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.03437091 |
| 12 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.99590806 |
| 13 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.98555033 |
| 14 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.97719648 |
| 15 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.95671411 |
| 16 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.93444093 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.92130509 |
| 18 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.89794487 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87324706 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84074755 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.83751716 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.76974152 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.76580529 |
| 24 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.76271408 |
| 25 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.76162213 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75911812 |
| 27 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.71154090 |
| 28 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.70009509 |
| 29 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.69138179 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.66461785 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64472227 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.64310994 |
| 33 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.64193409 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.61350449 |
| 35 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.61127509 |
| 36 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59893946 |
| 37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56818089 |
| 38 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.56612246 |
| 39 | SA1_27219007_Chip-Seq_Bcells_Human | 1.56355638 |
| 40 | ERA_21632823_ChIP-Seq_H3396_Human | 1.55270560 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.55243975 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54646241 |
| 43 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.53447695 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.52492183 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.51879052 |
| 46 | P300_27268052_Chip-Seq_Bcells_Human | 1.50159185 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49553780 |
| 48 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.48382779 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48108788 |
| 50 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.47942470 |
| 51 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45750596 |
| 52 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.43429156 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42216244 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41664342 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41003418 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40482275 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39840735 |
| 58 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.39510335 |
| 59 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39220094 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.37744532 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36739919 |
| 62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34215598 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.31963735 |
| 64 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30891189 |
| 65 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.30749900 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30129453 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.29893012 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29415534 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27813008 |
| 70 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27163463 |
| 71 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.26568225 |
| 72 | MYC_22102868_ChIP-Seq_BL_Human | 1.25709549 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24641762 |
| 74 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.24408203 |
| 75 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.23833313 |
| 76 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.23457429 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20682924 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19740923 |
| 79 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.17101522 |
| 80 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17019114 |
| 81 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.16306146 |
| 82 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15446208 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14105861 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12654928 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12185236 |
| 86 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.11218113 |
| 87 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11013449 |
| 88 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10978980 |
| 89 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.10204335 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09529709 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08004602 |
| 92 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07719900 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07355081 |
| 94 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06696831 |
| 95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05379263 |
| 96 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.04349466 |
| 97 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01347255 |
| 98 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01202270 |
| 99 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99894910 |
| 100 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98760628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001986_abnormal_taste_sensitivity | 2.74716052 |
| 2 | MP0002653_abnormal_ependyma_morphology | 2.50358059 |
| 3 | MP0001968_abnormal_touch/_nociception | 2.27717127 |
| 4 | MP0003646_muscle_fatigue | 2.26174396 |
| 5 | MP0005671_abnormal_response_to | 2.21499109 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.18667500 |
| 7 | MP0004147_increased_porphyrin_level | 1.99851092 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 1.97325509 |
| 9 | MP0005360_urolithiasis | 1.87606724 |
| 10 | MP0002736_abnormal_nociception_after | 1.82744673 |
| 11 | MP0002163_abnormal_gland_morphology | 1.82736120 |
| 12 | MP0009840_abnormal_foam_cell | 1.79953904 |
| 13 | MP0002254_reproductive_system_inflammat | 1.75875105 |
| 14 | MP0005083_abnormal_biliary_tract | 1.75074645 |
| 15 | MP0000015_abnormal_ear_pigmentation | 1.73473370 |
| 16 | MP0000685_abnormal_immune_system | 1.68512732 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 1.67747091 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 1.65369272 |
| 19 | MP0003787_abnormal_imprinting | 1.65146465 |
| 20 | MP0004043_abnormal_pH_regulation | 1.61757826 |
| 21 | MP0005174_abnormal_tail_pigmentation | 1.60824452 |
| 22 | MP0003011_delayed_dark_adaptation | 1.59089985 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.59022511 |
| 24 | MP0003436_decreased_susceptibility_to | 1.50784790 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.50340594 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.49822066 |
| 27 | MP0009764_decreased_sensitivity_to | 1.48820461 |
| 28 | MP0008872_abnormal_physiological_respon | 1.46098962 |
| 29 | MP0005645_abnormal_hypothalamus_physiol | 1.42492630 |
| 30 | MP0001873_stomach_inflammation | 1.39367611 |
| 31 | MP0004142_abnormal_muscle_tone | 1.39004100 |
| 32 | MP0004133_heterotaxia | 1.38363657 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.36264125 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.33839644 |
| 35 | MP0001188_hyperpigmentation | 1.33489332 |
| 36 | MP0009745_abnormal_behavioral_response | 1.33352536 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.31295542 |
| 38 | MP0001800_abnormal_humoral_immune | 1.29765469 |
| 39 | MP0005025_abnormal_response_to | 1.29462517 |
| 40 | MP0001905_abnormal_dopamine_level | 1.29099328 |
| 41 | MP0000538_abnormal_urinary_bladder | 1.26537243 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.25731368 |
| 43 | MP0002723_abnormal_immune_serum | 1.25379321 |
| 44 | MP0005387_immune_system_phenotype | 1.25225643 |
| 45 | MP0001790_abnormal_immune_system | 1.25225643 |
| 46 | MP0003786_premature_aging | 1.25163630 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.24885429 |
| 48 | MP0001764_abnormal_homeostasis | 1.23659955 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.20697789 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.18165154 |
| 51 | MP0005332_abnormal_amino_acid | 1.17247605 |
| 52 | MP0008877_abnormal_DNA_methylation | 1.15663042 |
| 53 | MP0001970_abnormal_pain_threshold | 1.15224996 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.13563089 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.12908738 |
| 56 | MP0003186_abnormal_redox_activity | 1.12645110 |
| 57 | MP0001663_abnormal_digestive_system | 1.12179471 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.11020699 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.10644243 |
| 60 | MP0001819_abnormal_immune_cell | 1.10517828 |
| 61 | MP0002064_seizures | 1.09733201 |
| 62 | MP0003724_increased_susceptibility_to | 1.08511748 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.07184130 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.06464167 |
| 65 | MP0003878_abnormal_ear_physiology | 1.06464167 |
| 66 | MP0003879_abnormal_hair_cell | 1.05733272 |
| 67 | MP0009785_altered_susceptibility_to | 1.05658167 |
| 68 | MP0005365_abnormal_bile_salt | 1.05456825 |
| 69 | MP0004858_abnormal_nervous_system | 1.03907074 |
| 70 | MP0002102_abnormal_ear_morphology | 1.02829801 |
| 71 | MP0002735_abnormal_chemical_nociception | 1.02166834 |
| 72 | MP0006082_CNS_inflammation | 1.00207814 |
| 73 | MP0001529_abnormal_vocalization | 0.99672465 |
| 74 | MP0001835_abnormal_antigen_presentation | 0.97904069 |
| 75 | MP0003195_calcinosis | 0.97619163 |
| 76 | MP0004742_abnormal_vestibular_system | 0.97199790 |
| 77 | MP0001919_abnormal_reproductive_system | 0.95745270 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.94451860 |
| 79 | MP0002419_abnormal_innate_immunity | 0.93111862 |
| 80 | MP0005379_endocrine/exocrine_gland_phen | 0.92375199 |
| 81 | MP0005423_abnormal_somatic_nervous | 0.90835627 |
| 82 | MP0004381_abnormal_hair_follicle | 0.90543188 |
| 83 | MP0002272_abnormal_nervous_system | 0.89992590 |
| 84 | MP0005646_abnormal_pituitary_gland | 0.89690234 |
| 85 | MP0001756_abnormal_urination | 0.89094656 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.87513652 |
| 87 | MP0003303_peritoneal_inflammation | 0.87177965 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.85546756 |
| 89 | MP0002693_abnormal_pancreas_physiology | 0.84718774 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.83790919 |
| 91 | MP0001664_abnormal_digestion | 0.82836744 |
| 92 | MP0005310_abnormal_salivary_gland | 0.82590389 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.81335175 |
| 94 | MP0000716_abnormal_immune_system | 0.81222486 |
| 95 | MP0008469_abnormal_protein_level | 0.80940850 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.77938192 |
| 97 | MP0002557_abnormal_social/conspecific_i | 0.77015771 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.76282688 |
| 99 | MP0001502_abnormal_circadian_rhythm | 0.75889726 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.75388782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.44482832 |
| 2 | Congenital stationary night blindness (HP:0007642) | 3.33644253 |
| 3 | Mitochondrial inheritance (HP:0001427) | 3.33112360 |
| 4 | 3-Methylglutaconic aciduria (HP:0003535) | 3.31864700 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 3.24537326 |
| 6 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.23631095 |
| 7 | Increased CSF lactate (HP:0002490) | 3.13879652 |
| 8 | Hepatocellular necrosis (HP:0001404) | 2.97378203 |
| 9 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.85057041 |
| 10 | Severe visual impairment (HP:0001141) | 2.83713760 |
| 11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.82589323 |
| 12 | Hepatic necrosis (HP:0002605) | 2.80669539 |
| 13 | Acute encephalopathy (HP:0006846) | 2.80567952 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75316894 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 2.68958363 |
| 16 | Progressive microcephaly (HP:0000253) | 2.67427306 |
| 17 | Methylmalonic aciduria (HP:0012120) | 2.62630555 |
| 18 | Increased serum lactate (HP:0002151) | 2.60949331 |
| 19 | Type II lissencephaly (HP:0007260) | 2.60233031 |
| 20 | Progressive macrocephaly (HP:0004481) | 2.59439402 |
| 21 | Pendular nystagmus (HP:0012043) | 2.57284486 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.55346080 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.55346080 |
| 24 | Dicarboxylic aciduria (HP:0003215) | 2.50845531 |
| 25 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50845531 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 2.49067726 |
| 27 | Molar tooth sign on MRI (HP:0002419) | 2.49067726 |
| 28 | Microretrognathia (HP:0000308) | 2.48882944 |
| 29 | Abnormal drinking behavior (HP:0030082) | 2.45891165 |
| 30 | Polydipsia (HP:0001959) | 2.45891165 |
| 31 | Pancreatic cysts (HP:0001737) | 2.45123664 |
| 32 | Testicular atrophy (HP:0000029) | 2.43544209 |
| 33 | Opisthotonus (HP:0002179) | 2.43521696 |
| 34 | Increased muscle lipid content (HP:0009058) | 2.41093289 |
| 35 | Ragged-red muscle fibers (HP:0003200) | 2.40584529 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.37452767 |
| 37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.37295190 |
| 38 | Nephronophthisis (HP:0000090) | 2.34497356 |
| 39 | Lactic acidosis (HP:0003128) | 2.34012549 |
| 40 | Hypoplasia of the pons (HP:0012110) | 2.31680933 |
| 41 | Attenuation of retinal blood vessels (HP:0007843) | 2.30304404 |
| 42 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.28235097 |
| 43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27606414 |
| 44 | Rib fusion (HP:0000902) | 2.23176736 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.23152201 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.23152201 |
| 47 | Hyperalaninemia (HP:0003348) | 2.23152201 |
| 48 | Stomatitis (HP:0010280) | 2.14438132 |
| 49 | Abnormality of the pons (HP:0007361) | 2.13647531 |
| 50 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.13284007 |
| 51 | Optic disc pallor (HP:0000543) | 2.12844003 |
| 52 | Pancreatic fibrosis (HP:0100732) | 2.11119935 |
| 53 | Lipid accumulation in hepatocytes (HP:0006561) | 2.11076693 |
| 54 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.09840721 |
| 55 | Tubular atrophy (HP:0000092) | 2.08030893 |
| 56 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.05631388 |
| 57 | Ketosis (HP:0001946) | 2.05608970 |
| 58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02943147 |
| 59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02943147 |
| 60 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02943147 |
| 61 | Clumsiness (HP:0002312) | 2.00753461 |
| 62 | Polyphagia (HP:0002591) | 2.00531539 |
| 63 | Decreased circulating renin level (HP:0003351) | 2.00349528 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 1.96339912 |
| 65 | Abnormal protein glycosylation (HP:0012346) | 1.95928553 |
| 66 | Abnormal glycosylation (HP:0012345) | 1.95928553 |
| 67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.95928553 |
| 68 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.95928553 |
| 69 | Concave nail (HP:0001598) | 1.94972605 |
| 70 | Bile duct proliferation (HP:0001408) | 1.93131150 |
| 71 | Abnormal biliary tract physiology (HP:0012439) | 1.93131150 |
| 72 | Hyperthyroidism (HP:0000836) | 1.91824802 |
| 73 | Severe muscular hypotonia (HP:0006829) | 1.88642679 |
| 74 | Delayed CNS myelination (HP:0002188) | 1.88567740 |
| 75 | Obstructive lung disease (HP:0006536) | 1.84840890 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 1.84840890 |
| 77 | Pustule (HP:0200039) | 1.84570895 |
| 78 | Renal Fanconi syndrome (HP:0001994) | 1.82883344 |
| 79 | Cerebral edema (HP:0002181) | 1.82842734 |
| 80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81281006 |
| 81 | Patellar aplasia (HP:0006443) | 1.78948111 |
| 82 | Retinal dysplasia (HP:0007973) | 1.78437558 |
| 83 | Cerebellar dysplasia (HP:0007033) | 1.77995930 |
| 84 | Abolished electroretinogram (ERG) (HP:0000550) | 1.77918060 |
| 85 | Abnormal albumin level (HP:0012116) | 1.76209272 |
| 86 | Hypoalbuminemia (HP:0003073) | 1.76209272 |
| 87 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75916449 |
| 88 | Flat capital femoral epiphysis (HP:0003370) | 1.75194175 |
| 89 | Lethargy (HP:0001254) | 1.75022308 |
| 90 | Polyuria (HP:0000103) | 1.74888399 |
| 91 | True hermaphroditism (HP:0010459) | 1.74761308 |
| 92 | Respiratory failure (HP:0002878) | 1.74044910 |
| 93 | Increased hepatocellular lipid droplets (HP:0006565) | 1.72578923 |
| 94 | Lissencephaly (HP:0001339) | 1.70762794 |
| 95 | Increased serum ferritin (HP:0003281) | 1.70002603 |
| 96 | Emotional lability (HP:0000712) | 1.69789131 |
| 97 | Abnormality of the renal medulla (HP:0100957) | 1.69235258 |
| 98 | Agitation (HP:0000713) | 1.69182433 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.69038214 |
| 100 | Hypochromic anemia (HP:0001931) | 1.68396119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.14447276 |
| 2 | ZAK | 2.67635818 |
| 3 | LIMK1 | 2.58435684 |
| 4 | ADRBK2 | 2.54076185 |
| 5 | MAP3K11 | 2.51948696 |
| 6 | MAP4K1 | 2.40133225 |
| 7 | MAP4K2 | 2.38316243 |
| 8 | BCKDK | 2.17992381 |
| 9 | FRK | 2.15707998 |
| 10 | TESK2 | 2.07081547 |
| 11 | TAOK2 | 2.06025140 |
| 12 | IRAK4 | 2.04177594 |
| 13 | TAOK3 | 2.01815465 |
| 14 | PIM2 | 1.90136181 |
| 15 | SIK2 | 1.89943958 |
| 16 | ERN1 | 1.84333489 |
| 17 | MAP2K6 | 1.75681472 |
| 18 | DAPK2 | 1.74930128 |
| 19 | TXK | 1.58789122 |
| 20 | TNK2 | 1.58244809 |
| 21 | DYRK2 | 1.56756475 |
| 22 | ACVR1B | 1.55074000 |
| 23 | NME2 | 1.54667838 |
| 24 | VRK2 | 1.53746572 |
| 25 | WNK4 | 1.49471098 |
| 26 | ABL2 | 1.45729166 |
| 27 | INSRR | 1.43165020 |
| 28 | GRK6 | 1.40062664 |
| 29 | GRK1 | 1.39401798 |
| 30 | BLK | 1.38755572 |
| 31 | KDR | 1.33050705 |
| 32 | STK16 | 1.24758133 |
| 33 | PRKD2 | 1.18065173 |
| 34 | RPS6KA5 | 1.14043953 |
| 35 | PINK1 | 1.11166717 |
| 36 | TRIB3 | 1.09848643 |
| 37 | CDK19 | 1.09270697 |
| 38 | IKBKB | 1.02974617 |
| 39 | TBK1 | 1.02721834 |
| 40 | CDC42BPA | 0.99526834 |
| 41 | MAPKAPK3 | 0.95542164 |
| 42 | MAP2K7 | 0.94671216 |
| 43 | BMPR1B | 0.94028460 |
| 44 | MUSK | 0.90052179 |
| 45 | PRKCI | 0.88956260 |
| 46 | MAPK13 | 0.88006595 |
| 47 | ADRBK1 | 0.87542611 |
| 48 | NME1 | 0.85414715 |
| 49 | MAP2K2 | 0.84657648 |
| 50 | DYRK3 | 0.83111985 |
| 51 | MAPK11 | 0.82528879 |
| 52 | CAMKK2 | 0.81711291 |
| 53 | DAPK1 | 0.80723207 |
| 54 | IRAK3 | 0.80036786 |
| 55 | CSNK1G3 | 0.79786463 |
| 56 | MATK | 0.78827739 |
| 57 | CAMKK1 | 0.77773089 |
| 58 | FES | 0.77126453 |
| 59 | TESK1 | 0.76824888 |
| 60 | MAP2K3 | 0.76435825 |
| 61 | RPS6KA6 | 0.74080238 |
| 62 | ZAP70 | 0.71572252 |
| 63 | PRKCQ | 0.69913197 |
| 64 | SRPK1 | 0.69681555 |
| 65 | CDK8 | 0.65801722 |
| 66 | SYK | 0.64621351 |
| 67 | NUAK1 | 0.62797785 |
| 68 | PIM1 | 0.60284470 |
| 69 | GRK5 | 0.60255930 |
| 70 | DYRK1B | 0.60168973 |
| 71 | MARK3 | 0.60156611 |
| 72 | TYK2 | 0.59589501 |
| 73 | PRKG2 | 0.58306035 |
| 74 | IKBKE | 0.58213728 |
| 75 | PRKCG | 0.57989187 |
| 76 | STK11 | 0.57716809 |
| 77 | PRKCZ | 0.57563876 |
| 78 | BRAF | 0.57323456 |
| 79 | LYN | 0.57262303 |
| 80 | IRAK2 | 0.56784902 |
| 81 | CSNK1G2 | 0.56249969 |
| 82 | PKN1 | 0.53911444 |
| 83 | AURKA | 0.52167690 |
| 84 | GRK7 | 0.51856507 |
| 85 | TAOK1 | 0.51141178 |
| 86 | PTK6 | 0.50965624 |
| 87 | PDPK1 | 0.49779542 |
| 88 | HIPK2 | 0.49245006 |
| 89 | RPS6KL1 | 0.48487572 |
| 90 | RPS6KC1 | 0.48487572 |
| 91 | ICK | 0.47629570 |
| 92 | CSNK1A1L | 0.47248607 |
| 93 | CAMK1 | 0.46417679 |
| 94 | RPS6KA2 | 0.44903777 |
| 95 | CAMK4 | 0.43718871 |
| 96 | MAPK12 | 0.43611890 |
| 97 | BTK | 0.43038648 |
| 98 | LCK | 0.40959184 |
| 99 | OXSR1 | 0.40779041 |
| 100 | NEK2 | 0.40387402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 5.06652370 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.49085469 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.10774558 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.78276586 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.63558425 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.55918747 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.18779552 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.15334815 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.06449025 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.05827863 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96388290 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.95514343 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.94154681 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87878986 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.85992836 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84995090 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84619660 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.71560937 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.71148705 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66656977 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66191768 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.63579203 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63292853 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.61161756 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.39442132 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38842488 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.31792751 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31528926 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.30404077 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.23767110 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22378017 |
| 32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.16101177 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13818371 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.13158877 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12130039 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.10915974 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.10809422 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.09833788 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07592451 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06868563 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03371456 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 0.95791529 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94245628 |
| 44 | Nicotine addiction_Homo sapiens_hsa05033 | 0.88123938 |
| 45 | Purine metabolism_Homo sapiens_hsa00230 | 0.87540818 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86723226 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85719730 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85419675 |
| 49 | Metabolic pathways_Homo sapiens_hsa01100 | 0.84952043 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83893687 |
| 51 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82660660 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80824127 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79298524 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78988816 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77382510 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76867707 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74931012 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74645017 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71393262 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70948242 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70931352 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68635701 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66853687 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66536143 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.64997292 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63959688 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.61032862 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60143376 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59793376 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58624119 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57353377 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56801156 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56544449 |
| 74 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52101711 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50954286 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50063060 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47240096 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46833627 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46389963 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44945302 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43595922 |
| 82 | DNA replication_Homo sapiens_hsa03030 | 0.43570906 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42027992 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41759203 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40355113 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40275530 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37547716 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36279688 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34921754 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32672459 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.31587325 |
| 92 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31204047 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29630562 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29022875 |
| 95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28687650 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28030536 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26453577 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.25843799 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23438790 |
| 100 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.23188745 |

